Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dongkook Lifescience is a South Korean healthcare company specializing in diagnostic imaging solutions and medical devices. Spun off from Dongkook Pharmaceutical in 2017, the company has established itself as a market leader in the domestic contrast media sector. Its core product portfolio includes contrast agents such as Pamiray and Ioray, which are used in CT and MRI procedures. In addition to pharmaceuticals, the company distributes advanced medical equipment, including mobile CT scanners and ultrasound systems. Dongkook Lifescience operates a dedicated manufacturing facility in Jincheon, which adheres to international GMP standards. The company continues to expand its global footprint through exports to over 50 countries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dongkook Lifescience.